| abstract |
This invention relates to compounds that are agonists of the muscarinic M 1 receptor and/or M 4 receptor and which are useful in the treatment of muscarinic M 1 /M 4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula (1a) n nor a salt thereof, wherein p, q, r, s, Q, R 3 and R 4 are as defined herein. |